Articles

51. Managing Outsourcing For Complex Formulations 10/28/2022

    Despite the growing body of research and scientific knowledge, perhaps the biggest challenge with LNP formulation is the journey into the unknown.

52. Aktiv Pharma Group To Participate In The FDA Emerging Technology Program 9/26/2022

    Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP)

53. Drug Product Services: Pre-Formulation To Commercial-Scale Production 8/17/2022

    Our experts support clients with pre-formulation, formulation, process and analytical development, as well as production and registration. We’ve worked on a range of both oral solid dosage and injectable projects for clients over the years.

54. Reducing Lead Time & Optimizing Costs 8/2/2022

    Explore how the use of this component platform produces significant savings, reduces elastomer SKU complexity, and increases speed to market.

55. New Technologies To Improve Solubility Of Brick Dust Compounds 7/13/2022

    David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

56. CDMOs Step Up Parenteral Manufacturing Support 7/4/2022

    Jeff Clement, Executive Director, CDMO Business Development North America, discusses the impact of the pandemic on CDMOs and parenteral market trends.

57. Easy-To-Use 1 mL Disposable Autoinjector 6/8/2022

    BD Physioject™ 1 mL Disposable Autoinjector is an easy-to-use autoinjector designed to deliver fixed dose injections subcutaneously.

58. A CDMO With Oral Solid Dose And Sterile Injectable Expertise 6/6/2022

    Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.

59. Glass Prefillable Syringe Solution Delivering Complex Biologics 5/9/2022

    BD Neopak™ XtraFlow™ Glass Prefillable Syringe solution leverages 8 mm needle length in combination with thin wall cannula to reduce pressure drop and enhance flow.

60. Combination Products 4/28/2022

    Kymanox provides turnkey services to bring your product from concept to commercialization — and helps keep your product on the market. Kymanox has expertise in injectables (e.g., syringes, mechanical and electromechanical autoinjectors, wearable injectors, dual chamber systems, reconstitution systems), respiratory combination products (e.g., metered dose inhalers, dry powder inhalers, nasal sprays), and in ocular products (e.g., multi-dose containers, single-use injectables).